OrbiMed-backed Suraksha Diagnostic files IPO papersOrbiMed-backed Suraksha Diagnostic has filed the draft red herring prospectus (DRHP) with capital markets regulator SEBI to float an initia...
Arcatron Mobility raise growth capital from OrbiMed, a global healthcare-focused investment firmArcatron Mobility has raised growth capital from OrbiMed, a global healthcare-focused investment firm. The funds will be used to increase R...
Donald Trump's lawsuit over 'Steele dossier' thrown out by UK courtTrump, the frontrunner for the 2024 Republican presidential nomination, had sued Orbis Business Intelligence about claims in a dossier writ...
Orbis Financial Corporation raises Rs 102 croreOrbis Financial raises Rs 102 crore for market position strengthening, secures funds from investor Ashish Kacholia. The firm, founded in 20...
Trump's lawsuit against Steele's firm continues in UK court amid legal challengesFormer US President Donald Trump is continuing his legal battle against Orbis Business Intelligence over the negative charges made in Chris...
Trump sues ex-British spy over dossier containing 'shocking and scandalous claims'Donald Trump is suing the company founded by Christopher Steele, the former British spy who compiled a report containing unverified claims ...
Innvolution secures growth capital from OrbiMed to advance R&D, expand product line and enter global marketsInnvolution has recently received substantial growth capital from OrbiMed, an investment firm dedicated to healthcare
Ashish Kacholia takes part in Orbis Financial's Rs 111-crore fundraisingThe company is also the custodian for institutional investors with forward looking services designed and customised to equip mutual fund ho...
India loses USD 118 bn annually in cumulative GNI due to childhood blindness: ReportLaunched at the 16th edition of 'VISION 2020: The Right to Sight - INDIA' national conference held recently in West Bengal, it highlighted ...
Vivimed Labs gets additional $7.5 million funding from OrbiMed AsiaThe company had earlier received USD 42.5 million from OrbiMed Asia in September 2017, Vivimed Labs said in a BSE filing.
OrbiMed to invest $40 million in Suraksha DiagnosticsSuraksha, promoted by Panorama Group, operates more than 30 centres including polyclinics and has expanded services to include cardiology ,...
- Shasun Pharmaceuticals to sell 11.93 stake to US firm OrbiMed for Rs 50 crore
Shasun Pharmaceuticals said its board has approved to sell 11.93 per cent stake to US- based healthcare investment firm OrbiMed for Rs 50 c...
- PE funds to buy stakes in Kerala Institute of Medical Sciences
Private equity funds OrbiMed and Ascent Capital will pick up a minority stake in Kerala Institute of Medical Sciences for close to Rs 170 c...
- Citi pockets Rs 175 crore from Polaris stake sale
Citi has made nearly Rs 175 crore in the last few months by shedding over 10% of its stake in mid-tier company Polaris Software Lab.
- Citi continues to sell Polaris shares
Citi completed yet another round of selling mid-tier company Polaris Software Lab’s shares in the open market on Tuesday.
- Citi continues to divest stake in Polaris
Citi completed another round of selling mid-tier software company Polaris Software Lab’s shares in the open market on Friday.
- Citi continues to divest stake in Polaris
Citi completed its third round of selling mid-tier software company Polaris Software Lab’s shares in the open market on Wednesday.